N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
- PMID: 25153349
- DOI: 10.1016/j.canlet.2014.06.023
N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
Abstract
Although NDRG2 has recently been found to be a candidate tumor suppressor, its precise role in the epithelial-mesenchymal transition (EMT) is not well understood. In the present study, we demonstrated that NDRG2 overexpression in MDA-MB-231 cells down-regulated the expression of Snail, a transcriptional repressor of E-cadherin and a key regulator of EMT, as well as the phosphorylation of signal transducer and activator of transcription 3 (STAT3), an oncogenic transcription factor that is activated in many human malignancies including breast cancer. In addition, we confirmed that the expression of Snail and phospho-STAT3 was recovered when NDRG2 was knocked down by siRNA in MCF7 cells in which NDRG2 is endogenously expressed. Interestingly, MDA-MB-231-NDRG2 cells showed remarkably decreased Snail expression after treatment with JSI-124 (also known as cucurbitacin I) or Stattic, STAT3 inhibitors, compared to MDA-MB-231-mock cells. Moreover, STAT3 activation by EGF treatment induced higher Snail expression, and NDRG2 overexpression resulted in the inhibition of Snail expression in MDA-MB-231 cells stimulated by EGF in the absence or presence of STAT3 inhibitor. Treatment of MDA-MB-231 cells with STAT3 inhibitor led to a moderate decrease in wound healing and migration capacity, whereas STAT3 inhibitor treatment of MDA-MB-231-NDRG2 cells resulted in a significant attenuation of migration in both resting and EGF-stimulated cells. Collectively, our data demonstrate that the inhibition of STAT3 signaling by NDRG2 suppresses EMT progression of EMT via the down-regulation of Snail expression.
Keywords: Breast cancer; EMT; NDRG2; STAT3; Snail.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.Int J Mol Sci. 2022 Aug 19;23(16):9365. doi: 10.3390/ijms23169365. Int J Mol Sci. 2022. PMID: 36012631 Free PMC article. Review.
-
EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.Oncotarget. 2016 Dec 20;7(51):85021-85032. doi: 10.18632/oncotarget.13116. Oncotarget. 2016. PMID: 27829223 Free PMC article.
-
Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.Oncotarget. 2016 Jan 5;7(1):209-23. doi: 10.18632/oncotarget.6228. Oncotarget. 2016. PMID: 26506239 Free PMC article. Review.
-
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.Int J Oncol. 2014 May;44(5):1643-51. doi: 10.3892/ijo.2014.2310. Epub 2014 Feb 21. Int J Oncol. 2014. PMID: 24573038
-
Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.J Am Coll Surg. 2013 Jul;217(1):17-26; discussion 26. doi: 10.1016/j.jamcollsurg.2013.02.025. Epub 2013 Apr 23. J Am Coll Surg. 2013. PMID: 23619316
Cited by
-
NDRGs in Breast Cancer: A Review and In Silico Analysis.Cancers (Basel). 2024 Mar 29;16(7):1342. doi: 10.3390/cancers16071342. Cancers (Basel). 2024. PMID: 38611020 Free PMC article. Review.
-
Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review).Int J Oncol. 2024 May;64(5):48. doi: 10.3892/ijo.2024.5636. Epub 2024 Mar 15. Int J Oncol. 2024. PMID: 38488027 Free PMC article. Review.
-
Anticancer Effect of E26 Transformation-Specific Homologous Factor through the Induction of Senescence and the Inhibition of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.Cancers (Basel). 2023 Nov 2;15(21):5270. doi: 10.3390/cancers15215270. Cancers (Basel). 2023. PMID: 37958443 Free PMC article.
-
The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.Int J Mol Sci. 2022 Aug 19;23(16):9365. doi: 10.3390/ijms23169365. Int J Mol Sci. 2022. PMID: 36012631 Free PMC article. Review.
-
MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway.Bioengineered. 2022 Jan;13(1):83-95. doi: 10.1080/21655979.2021.2006974. Bioengineered. 2022. PMID: 34951340 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous